Pictet Asset Management Holding SA Has $797,000 Stake in Inspire Medical Systems, Inc. (NYSE:INSP)

Pictet Asset Management Holding SA increased its position in Inspire Medical Systems, Inc. ( NYSE:INSP – Free Report ) by 14.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC.

The fund owned 4,298 shares of the company’s stock after buying an additional 536 shares during the period. Pictet Asset Management Holding SA’s holdings in Inspire Medical Systems were worth $797,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company.



Smartleaf Asset Management LLC increased its stake in shares of Inspire Medical Systems by 178.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 357 shares of the company’s stock worth $66,000 after purchasing an additional 229 shares during the last quarter.

Merit Financial Group LLC acquired a new position in Inspire Medical Systems during the fourth quarter worth $313,000. Public Employees Retirement System of Ohio raised its holdings in Inspire Medical Systems by 9.4% during the third quarter.

Public Employees Retirement System of Ohio now owns 36,361 shares of the company’s stock valued at $7,674,000 after buying an additional 3,125 shares in the last quarter. Jennison Associates LLC acquired a new stake in shares of Inspire Medical Systems in the fourth quarter worth about $8,821,000. Finally, Janney Montgomery Scott LLC boosted its stake in shares of Inspire Medical Systems by 248.

5% during the 4th quarter. Janney Montgomery Scott LLC now owns 4,806 shares of the company’s stock worth $891,000 after acquiring an additional 3,427 shares in the last quarter. Institutional investors own 94.

91% of the company’s stock. Inspire Medical Systems Trading Up 5.5 % Shares of INSP stock opened at $149.

72 on Tuesday. Inspire Medical Systems, Inc. has a 1 year low of $123.

00 and a 1 year high of $257.40. The firm’s 50 day moving average is $175.

25 and its 200-day moving average is $187.63. The firm has a market capitalization of $4.

46 billion, a price-to-earnings ratio of 86.54, a PEG ratio of 2.86 and a beta of 1.

39. Insider Activity at Inspire Medical Systems In other Inspire Medical Systems news, CTO John Rondoni sold 583 shares of the company’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $170.

49, for a total transaction of $99,395.67. Following the completion of the sale, the chief technology officer now owns 10,424 shares in the company, valued at approximately $1,777,187.

76. The trade was a 5.30 % decrease in their position.

The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink . Also, insider Randy Ban sold 25,584 shares of the firm’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $183.

50, for a total value of $4,694,664.00. Following the completion of the transaction, the insider now owns 7,259 shares in the company, valued at $1,332,026.

50. This represents a 77.90 % decrease in their ownership of the stock.

The disclosure for this sale can be found here . 4.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In A number of research analysts recently weighed in on the company. Morgan Stanley cut their price objective on Inspire Medical Systems from $230.00 to $220.

00 and set an “overweight” rating on the stock in a research note on Tuesday, February 11th. Wells Fargo & Company reduced their price objective on shares of Inspire Medical Systems from $198.00 to $195.

00 and set an “equal weight” rating for the company in a research note on Tuesday, February 11th. Piper Sandler lowered their target price on shares of Inspire Medical Systems from $260.00 to $233.

00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Robert W. Baird cut their target price on shares of Inspire Medical Systems from $252.

00 to $248.00 and set an “outperform” rating for the company in a research report on Tuesday, February 11th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $234.

00 price target (down from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock.

According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $226.70.

Check Out Our Latest Analysis on INSP About Inspire Medical Systems ( Free Report ) Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. Read More Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.

com's FREE daily email newsletter ..